よむ、つかう、まなぶ。
資料４－４ 研究報告の報告状況［532KB］ (20 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_64439.html |
| 出典情報 | 薬事審議会 医薬品等安全対策部会（令和7年度第2回 10／24）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
研究報告の報告状況
（2025年4月1日～2025年7月31日）
NO 一般名
文献名
193 ロスバスタチンカルシウム
Ahluwalia, S. et al. (Government Medical College and
Hospital, Chandigarh, India). Comparative assessment of the
risk of new-onset diabetes mellitus between proprotein
convertase subtilisin/kexin type 9 inhibitors and statins: An
analysis of FDA Adverse Event Reporting System data. Brit.
J. Clin. Pharmacol.. 2025; 91(2): 583-584-.
194 ロスバスタチンカルシウム
Mehra, A. et al. (University of New Haven, CT., USA).
Comparative risk of statin-induced diabetes mellitus: A
disproportionality analysis of pitavastatin, rosuvastatin, and
atorvastatin using FDA Adverse Event Reporting System
(FAERS) data. Brit. J. Clin. Pharmacol.. 2025; 91(2): 585-.
195 ミルリノン
Smith, M. et al. (Detroit Medical Center, MI., USA).
Milrinone use and complications in critically ill adults. Crit.
Care Med.. 2025; 53(Suppl.1): 125-.
196 レベチラセタム
Maxim Grymonprez,Laura Carnoy,Andreas Capiau,Koen
Boussery,Els Mehuys,Tine L. De Backer,Stephane
Steurbaut,and Lies Lahousse. Impact of P-glycoprotein and
CYP3A4-interacting drugs on clinical outcomes in patients
with atrial fibrillation using non-vitamin K antagonist oral
anticoagulants: a nationwide cohort study. Eur Heart J
Cardiovasc Pharmacother. 2023; 9(8): 722-730.
197 レベチラセタム
Mohammed Abou Kaoud,Ran Nissan,Amitai Segev,Avi
Sabbag,David Orion,Elad Maor. Levetiracetam interaction
with direct oral anticoagulants:a pharmacovigilance study.
CNS Drugs. 2023; 37(12): 1111-1121.
198
ピタバスタチンカルシウム
ロスバスタチンカルシウム
Kazuhiro Kawabe,Kanako Izumi,Naoko Fukasawa,Momoko
Takashina,Minami Taguchi,Hirofumi Koike,Yukiko Sahashi,
Nobuhiro Ooba. Association between statin use and cataract
formation in a retrospective cohort study using Japanese
health screening and claims data. Scientific Reports. 2025;
15: 13594-.
Jihun Song, Seong Rae Kim, Yu-Jin Kim, Sun Jae Park,
アダリムマブ（遺伝子組換え）［後続３］ Seogsong Jeong, Sang Min Park, Risk of hematologic
199 エタネルセプト（遺伝子組換え）［後続 malignancies in psoriasis and rheumatoid arthritis patients
１］
using long term TNF-α inhibitors: a retrospective
nationwide study, Scientific reports. 2025;15(1)：7949
Sun, Jiyu 1 ; Lee, Hyo Jin 2 ; Lee, Jung-Kyu 2 ; Park, Tae
Yeon 2 ; Heo, Eun Young 2 ; Kim, Deog Kyeom 2 ; Lee,
フルチカゾンプロピオン酸エステル・ホ
200
Hyun Woo 2. Impact of inhaled corticosteroids on metabolic
ルモテロールフマル酸塩水和物
dysfunction-associated steatotic liver disease risk in COPD
patients. Respiratory Medicine and Research. 2025; 87.
201 アスピリン
Wadstrom, H. et al. Non-steroidal anti-inflammatory drugs
and risk of kidney cancer: A Swedishb nationwide cohort
study in the general and high-use populations. J. Intern.
Med. 297(5),505-517,2025.
20
（2025年4月1日～2025年7月31日）
NO 一般名
文献名
193 ロスバスタチンカルシウム
Ahluwalia, S. et al. (Government Medical College and
Hospital, Chandigarh, India). Comparative assessment of the
risk of new-onset diabetes mellitus between proprotein
convertase subtilisin/kexin type 9 inhibitors and statins: An
analysis of FDA Adverse Event Reporting System data. Brit.
J. Clin. Pharmacol.. 2025; 91(2): 583-584-.
194 ロスバスタチンカルシウム
Mehra, A. et al. (University of New Haven, CT., USA).
Comparative risk of statin-induced diabetes mellitus: A
disproportionality analysis of pitavastatin, rosuvastatin, and
atorvastatin using FDA Adverse Event Reporting System
(FAERS) data. Brit. J. Clin. Pharmacol.. 2025; 91(2): 585-.
195 ミルリノン
Smith, M. et al. (Detroit Medical Center, MI., USA).
Milrinone use and complications in critically ill adults. Crit.
Care Med.. 2025; 53(Suppl.1): 125-.
196 レベチラセタム
Maxim Grymonprez,Laura Carnoy,Andreas Capiau,Koen
Boussery,Els Mehuys,Tine L. De Backer,Stephane
Steurbaut,and Lies Lahousse. Impact of P-glycoprotein and
CYP3A4-interacting drugs on clinical outcomes in patients
with atrial fibrillation using non-vitamin K antagonist oral
anticoagulants: a nationwide cohort study. Eur Heart J
Cardiovasc Pharmacother. 2023; 9(8): 722-730.
197 レベチラセタム
Mohammed Abou Kaoud,Ran Nissan,Amitai Segev,Avi
Sabbag,David Orion,Elad Maor. Levetiracetam interaction
with direct oral anticoagulants:a pharmacovigilance study.
CNS Drugs. 2023; 37(12): 1111-1121.
198
ピタバスタチンカルシウム
ロスバスタチンカルシウム
Kazuhiro Kawabe,Kanako Izumi,Naoko Fukasawa,Momoko
Takashina,Minami Taguchi,Hirofumi Koike,Yukiko Sahashi,
Nobuhiro Ooba. Association between statin use and cataract
formation in a retrospective cohort study using Japanese
health screening and claims data. Scientific Reports. 2025;
15: 13594-.
Jihun Song, Seong Rae Kim, Yu-Jin Kim, Sun Jae Park,
アダリムマブ（遺伝子組換え）［後続３］ Seogsong Jeong, Sang Min Park, Risk of hematologic
199 エタネルセプト（遺伝子組換え）［後続 malignancies in psoriasis and rheumatoid arthritis patients
１］
using long term TNF-α inhibitors: a retrospective
nationwide study, Scientific reports. 2025;15(1)：7949
Sun, Jiyu 1 ; Lee, Hyo Jin 2 ; Lee, Jung-Kyu 2 ; Park, Tae
Yeon 2 ; Heo, Eun Young 2 ; Kim, Deog Kyeom 2 ; Lee,
フルチカゾンプロピオン酸エステル・ホ
200
Hyun Woo 2. Impact of inhaled corticosteroids on metabolic
ルモテロールフマル酸塩水和物
dysfunction-associated steatotic liver disease risk in COPD
patients. Respiratory Medicine and Research. 2025; 87.
201 アスピリン
Wadstrom, H. et al. Non-steroidal anti-inflammatory drugs
and risk of kidney cancer: A Swedishb nationwide cohort
study in the general and high-use populations. J. Intern.
Med. 297(5),505-517,2025.
20